Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

The primary difference between mini gastric bypass surgery and a full gastric bypass is that the mini version of the surgery is performed in a modified manner that involves less intestinal rerouting and a shorter overall surgery time. After surgery, you should avoid nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen (Motrin, Advil) and naproxen (Aleve). NSAIDs increase the risk of stomach ulcers. Patients who had gastric bypass surgery should avoid these medications indefinitely. Bread, Rice... +More

Common gastritis symptoms include stomach pain, bloating, nausea, vomiting, and indigestion. Chronic gastritis may cause long-term discomfort, while acute cases can result in sharp pain. Treatment often involves antacids, antibiotics (for bacterial infections), and lifestyle modifications like dietary changes.

Chronic gastritis is a long-lasting inflammation of the stomach lining that can lead to complications like ulcers or an increased risk of stomach cancer. Common causes include H. pylori infection or autoimmune disorders. Patients may need ongoing treatment with medications to reduce stomach acid and eradicate infections.